Home › Stargardt Disease › Pennsylvania
Stargardt Disease clinical trials in Pennsylvania
3 studies for Stargardt Disease are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Study of ALK-001 on the Progression of Stargardt Disease
- Erie Retina Research, Erie
- Mid Atlantic Retina, Philadelphia
- UPMC Vision Institute, Pittsburgh
RecruitingPhase 3
Ages 8 to 45 · All sexes · Updated Sep 18, 2026 · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Wills Eye Physicians - Mid Atlantic Retina, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
- UPMC Vision Institute, Pittsburgh
RecruitingPhase 1/2
Ages 16 and older · All sexes · Updated Apr 15, 2026 · NCT07439887From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.